Coming up: Researchers discuss vaccine development, continued efforts on novel coronavirus
A vaccine candidate for the novel coronavirus hit a new milestone and entered phase two of clinical trials last week. But what does that mean in terms of how soon this vaccine — or others — might be ready for public use?
This vaccine is far from the only trial underway, with researchers around the world racing to safely produce a product — or products — to protect against COVID-19 infection.
Join Kerri Miller on our weekly show focusing on the science of the novel coronavirus as she talks with a vaccinologist and a virologist about how the vaccine development process works; the speed of the science happening during a pandemic; and answer listener questions.
Guests:
Deborah Fuller is a vaccinologist and professor of microbiology at the University of Washington School of Medicine
Angela Rasmussen is a virologist and associate research scientist at Columbia University’s Mailman School of Public Health.
Subscribe to the MPR News with Kerri Miller podcast on: Apple Podcasts, Google Podcasts , Spotify or RSS.
Create a More Connected Minnesota
MPR News is your trusted resource for the news you need. With your support, MPR News brings accessible, courageous journalism and authentic conversation to everyone - free of paywalls and barriers. Your gift makes a difference.